{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-018526","form_type":"8-K/A","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2024-02-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.557936+00:00","generated_at":"2026-06-05T06:11:17.597735+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ABVC BioPharma amends convertible note with $1.00 floor price; cash payment on floor conversions","bullets":["Amendment to $1M secured convertible note sets floor conversion price at $1.00 per share.","Cash payment required if conversion price equals floor price, based on formula linked to VWAP.","Initial shareholder meeting deadline extended one month to April 17, 2024.","Amendment adopted to comply with Nasdaq listing requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-018526","json":"https://secwatch.observer/filing/0001213900-24-018526.json","markdown":"https://secwatch.observer/filing/0001213900-24-018526.md","text":"https://secwatch.observer/filing/0001213900-24-018526.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024018526/0001213900-24-018526-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024018526/ea0200876-8ka1_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T06:11:17.597735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"733eecfcdfd4a6f79a25d59f6e993dfe4ab37d58","claim":"ABVC BIOPHARMA, INC. amended Amendment with Lind Global Fund II, LP valued at conversion price shall have a floor price of $1.00 (effective 2024-01-17).","evidence_excerpt":"the parties entered into an amendment to the Note, pursuant to which the conversion price shall have a floor price of $1.00 (the “Amendment”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390024018526/0001213900-24-018526-index.htm","confidence":1.0,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"Lind Global Fund II, LP"},{"label":"Value","value":"conversion price shall have a floor price of $1.00"},{"label":"Effective","value":"2024-01-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}